GSKShanghai, Shanghai, China
Medical advisor in pharmaceuticals
0649: Belimumab Real-World Effectiveness in Chinese Patients with Systemic Lupus Erythematosus: Interim Analysis of an Ambidirectional, Observational Cohort Study (RELIABLE)
Sunday, October 26, 202510:30 AM - 12:30 PM Central Time
Disclosure(s): GlaxoSmithKlein(GSK): Employee (Ongoing)